Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Founder of scandal-hit drugmaker Servier dies at 92

Published 17/04/2014, 09:17

PARIS (Reuters) - Jacques Servier, founder and president of France's second-largest drugmaker, has died before his trial over Mediator, a weight-loss pill at the centre of the country's biggest public health scandal in years.

The 92-year-old billionaire doctor, who founded the privately held drugmaker that bears his name 60 years ago, died on Wednesday at his home, the company said late that evening.

Servier died of old age, a company spokeswoman said on Thursday.

He was placed under investigation in 2012 on suspicion of manslaughter for his role in the Mediator scandal and had always denied any wrongdoing.

A trial is expected in the first half of 2015 to determine whether the company misled patients and authorities about the pill, suspected of causing heart-valve disorders.

Officials have blamed at least 500 deaths on Mediator, which

was marketed to overweight diabetics but often prescribed for weight loss. The drug was pulled from the French market in 2009, about a decade after its withdrawal from Spain, Italy and the United States.

Servier posted revenue of 4.2 billion euros (3.4 billion pounds) in 2013, making it France's second-biggest drugmaker by sales behind Sanofi 4:SASY. The fortune of Servier's founder was estimated at 2.3 billion euros by economic magazine Challenges.

(Reporting by Natalie Huet; Editing by Erica Billingham)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.